Literature DB >> 2703167

Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements.

E Vesterinen1, M Forss, U Nieminen.   

Abstract

A total of 520 new cases of cervical carcinoma were treated at the Department of Obstetrics and Gynecology, Helsinki University Central Hospital, in 1976 through 1980. Of these carcinomas, 95 (18.3%) were pure adenocarcinomas and 17 (3.3%) represented adenosquamous tumors. The mean age was 58.9 years (range 23-88 years). The age distribution was similar in patients with and without malignant glandular elements and the peak incidence was in the age group 60-69 years. In patients with adenocarcinoma, stage I was overrepresented (62.1%) whereas epidermoid carcinomas were more evenly distributed among various stages. The overall 5-year survival rate was 63.1%, with the corresponding corrected rate being 69.1%. The survival rate for patients with adenocarcinoma did not differ significantly from that for patients with squamous cell tumor. It is concluded that in our population the increasing frequency of cervical adenocarcinoma has not influenced the favorable results of the 5-year study. This disease, however, deserves more attention since its etiology, pathogenesis, and biology are still largely unresolved.

Entities:  

Mesh:

Year:  1989        PMID: 2703167     DOI: 10.1016/0090-8258(89)90602-1

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma.

Authors:  Eduardo Cambruzzi; Cláudio Galleano Zettler; Cláudio Osmar Pereira Alexandre
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

Review 2.  Recent advances in invasive adenocarcinoma of the cervix.

Authors:  Simona Stolnicu; Lien Hoang; Robert A Soslow
Journal:  Virchows Arch       Date:  2019-06-17       Impact factor: 4.064

3.  Nucleolar organiser regions in adenocarcinoma in situ and invasive adenocarcinoma of the cervix.

Authors:  J F Darne; S V Polacarz; E Sheridan; D Anderson; R Ginsberg; F Sharp
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

4.  International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.

Authors:  Simona Stolnicu; Iulia Barsan; Lien Hoang; Prusha Patel; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Malcolm C Pike; Esther Oliva; Kay J Park; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2018-02       Impact factor: 6.394

5.  Claudin-18 as a Promising Surrogate Marker for Endocervical Gastric-type Carcinoma.

Authors:  Takako Kiyokawa; Lien Hoang; Anna Pesci; Isabel Alvarado-Cabrero; Esther Oliva; Kay J Park; Robert A Soslow; Simona Stolnicu
Journal:  Am J Surg Pathol       Date:  2022-05-01       Impact factor: 6.298

6.  Morphologic Features of Gastric-type Cervical Adenocarcinoma in Small Surgical and Cytology Specimens.

Authors:  Gulisa Turashvili; Elizabeth G Morency; Mihaela Kracun; Deborah F DeLair; Sarah Chiang; Robert A Soslow; Kay J Park; Rajmohan Murali
Journal:  Int J Gynecol Pathol       Date:  2019-05       Impact factor: 2.762

7.  Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes.

Authors:  S V Polacarz; J Darne; E G Sheridan; R Ginsberg; F Sharp
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

8.  Trefoil Factor 2 (TFF2) as a Surrogate Marker for Endocervical Gastric-type Carcinoma.

Authors:  Kiyokawa Takako; Lien Hoang; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Isabel Alvarado-Cabrero; Esther Oliva; Kay J Park; Robert A Soslow; Simona Stolnicu
Journal:  Int J Gynecol Pathol       Date:  2021-01       Impact factor: 3.326

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.